Tag - BTRX

Developments

BioRestorative’s IFATS presentation features ThermoStem’s potential to deliver a superior efficacy and tolerability profile over GLP-1 drugs

BioRestorative Therapies (NASDAQ:BTRX) presented advancements in its metabolic program, ThermoStem, targeting obesity and metabolic disorders, at the 21st Annual International Federation for Adipose Therapeutics and...

September 25, 2024

Developments

BioResorative’s Chief Scientist named section editor of top-tier Journal of Translational Medicine

BioRestorative Therapies (NASDAQ:BTRX) announced that Francisco Silva, the company’s chief scientist and vice president of research and development, has been appointed section editor of the newly launched Regenerative...

July 23, 2024

Tag - BTRX

BioRestorative’s IFATS presentation features ThermoStem’s potential to deliver a superior efficacy and tolerability profile over GLP-1 drugs

BioResorative’s Chief Scientist named section editor of top-tier Journal of Translational Medicine

General

More